High-intensity focused ultrasound in the treatment of prostatic disease

R. S. Foster, R. Bihrle, N. T. Sanghvi, F. J. Fry, J. P. Donohue

Research output: Contribution to journalArticle

104 Scopus citations


Beginning in 1987, high-intensity focused ultrasound was investigated experimentally in a canine model to determine whether or not prostate tissue could be destroyed with good aiming and control. Subsequently a transrectal probe was developed and used to treat canine prostates in a formal study to determine whether or not this technology could be used to treat human benign prostatic hypertrophy. Next, after FDA approval, 15 patients were treated at Indiana University in the fall of 1992. Both canine and human studies have shown that high-intensity focused ultrasound administered via a transrectal probe is capable of creating prostate lesions without injury to intervening and surrounding tissue.

Original languageEnglish (US)
Pages (from-to)29-33
Number of pages5
JournalEuropean urology
Issue numberSUPPL. 1
StatePublished - Jan 1 1993


  • High-intensity focused ultrasound
  • Prostate

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'High-intensity focused ultrasound in the treatment of prostatic disease'. Together they form a unique fingerprint.

  • Cite this